MEDINET Co., Ltd. (TYO:2370)
Japan · Delayed Price · Currency is JPY 26.00
+1.00 (4.00%)
Aug 6, 2026, 1:03 PM JST
MEDINET Financials Overview
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '18 Sep 30, 2018 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
Revenue Revenue Growth | 998 | 998 | 1,704 | 1,909 | 1,674 | 1,843 |
Revenue Growth | -41.43% | -41.43% | -10.74% | 14.04% | -9.17% | -12.65% |
Gross Profit Gross Profit Growth | 330 | 330 | 769 | 860 | 672 | 824 |
Operating Income Operating Income Growth | -2,701 | -2,701 | -1,798 | -1,681 | -1,742 | -1,408 |
Net Income Net Income Growth | -3,048 | -3,048 | -2,603 | -1,643 | -1,712 | -1,580 |
Earnings Per Share EPS Growth | -26.77 | -26.77 | -27.23 | -18.01 | -19.27 | -17.93 |
EPS Growth | - | - | - | - | - | - |
Revenue by Segment
| Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '18 Sep 30, 2018 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
Cell Processing Industry Cell Processing Industry Growth | 994.53 | 994.53 | 1,703 | 1,877 | 1,666 | 1,841 |
Regenerative Medicine Etc. Product Business Regenerative Medicine Etc. Product Business Growth | 3.75 | 3.75 | 1.48 | 32.6 | 8.36 | 3 |
Total Total Growth | 998.28 | 998.28 | 1,704 | 1,909 | 1,674 | 1,844 |
| Fiscal Year | Current | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '18 Sep 30, 2018 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
Cash & Investments Cash & Investments Growth | 2,201 | 2,201 | 3,436 | 3,594 | 3,811 | 5,909 |
Total Debt Total Debt Growth | 72 | 72 | 127 | 1,037 | 1,001 | 878 |
Net Cash (Debt) Net Cash Growth | 2,129 | 2,129 | 3,309 | 2,557 | 2,810 | 5,031 |
Net Cash Growth | -35.66% | -35.66% | 29.41% | -9.00% | -44.15% | -26.13% |
Net Cash Per Share Net Cash Per Share Growth | 18.70 | 18.70 | 34.62 | 28.03 | 31.64 | 57.11 |
| Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '18 Sep 30, 2018 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
Operating Cash Flow Operating Cash Flow Growth | -2,499 | -2,499 | -1,333 | -1,088 | -1,567 | -1,020 |
Capital Expenditures CapEx Growth | -216 | -216 | -3 | -17 | -859 | -472 |
Free Cash Flow Free Cash Flow Growth | -2,715 | -2,715 | -1,336 | -1,105 | -2,426 | -1,492 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '18 Sep 30, 2018 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
Gross Margin | 33.07% | 33.07% | 45.13% | 45.05% | 40.14% | 44.71% |
Operating Margin | -270.64% | -270.64% | -105.52% | -88.06% | -104.06% | -76.40% |
Pretax Margin | -304.41% | -304.41% | -154.58% | -85.65% | -99.46% | -85.24% |
Profit Margin | -305.41% | -305.41% | -152.76% | -86.07% | -102.27% | -85.73% |
FCF Margin | -272.04% | -272.04% | -78.40% | -57.88% | -144.92% | -80.95% |
| Fiscal Year | Current | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 |
PS Ratio | 7.06 | 10.19 | 7.97 | 7.67 | 8.99 | 11.31 |